Your browser doesn't support javascript.
loading
Incidence, risk factors, and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy within 2 years.
Fan, Bo; Yokoyama, Minato; Kobayashi, Masaki; Nakamura, Yuki; Fujiwara, Motohiro; Ishikawa, Yudai; Fukuda, Shohei; Waseda, Yuma; Tanaka, Hajime; Yoshida, Soichiro; Fujii, Yasuhisa.
Afiliação
  • Fan B; Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Yokoyama M; Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Kobayashi M; Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Nakamura Y; Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Fujiwara M; Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Ishikawa Y; Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Fukuda S; Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Waseda Y; Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Tanaka H; Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Yoshida S; Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Fujii Y; Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
Int J Urol ; 31(2): 119-124, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37828800
ABSTRACT

OBJECTIVES:

To evaluate the incidence and risk factors of a 20% decrease from new baseline (NB)-estimated glomerular filtration rate (eGFR) within 2 years after radical nephrectomy (RN) and partial nephrectomy (PN) and to examine the difference in the incidence of end-stage renal disease (ESRD) with or without the 20% decrease.

METHODS:

This retrospective study included 238 patients undergoing RN and 369 undergoing PN for cT1a-cT3a renal cancer. The incidence of a 20% decrease from NB-eGFR within 2 years after RN/PN was examined and its potential risk factors including surgery type were assessed by multivariate logistic regression analysis. The development of ESRD was analyzed as an endpoint and its incidence was compared according to the presence or absence of the 20% decrease from NB-eGFR within 2 years.

RESULTS:

Overall, the 20% decrease from NB-eGFR within 2 years was observed in 37 patients (6.1%), including 10 (4.2%) and 27 (7.3%) after RN and PN, respectively (p = 0.117). Diabetes mellitus, proteinuria, and perioperative complications were shown to be independent risk factors for the 20% decrease from NB-eGFR, while surgery type was not. During the median follow-up of 65 months, the ESRD-free survival rate at 6 years was 75.5% and 99.6% in patients with and without the 20% decrease from NB-eGFR, respectively (p < 0.001), while no significant difference was observed between patients undergoing RN and PN (98.1% and 98.7%, p = 0.561).

CONCLUSIONS:

Because the incidence of ESRD after the 20% decrease from NB-eGFR within 2 years was as high as 24.5% at 6 years, these patients should be followed with utmost care.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Falência Renal Crônica / Neoplasias Renais Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Falência Renal Crônica / Neoplasias Renais Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article